FRANKLIN LAKES, N.J., June 23, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from ...

The conventional management of treatment-resistant, recurrent malignant ascites involves repeated large-volume paracentesis (needle drainage of fluid) procedures that are carried out in hospital. Most ...

An apple a day may keep the doctor away, but an at-home catheter system from BD has the potential to keep the entire hospital away. The PeritX system allows patients with ascites to regularly drain ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA’s 510(k) clearance for its PeritX Peritoneal Catheter System. The system is to be used for the drainage ...

Validation of urinary HE4 as a biomarker for ovarian cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.

Pleural Dynamics, an early-stage medical device startup developing solutions for the management of chronic, recurrent effusions and refractory ascites, has received FDA 510(k) clearance for its ...

Malignant ascites represent one of the most challenging complications of advanced intra-abdominal and gynaecological malignancies worldwide, imposing a profound impact on patient comfort, mobility and ...

Malignant ascites can develop with late stage pancreatic cancer. Ascites involves the buildup of fluid in the abdomen. Doctors can drain the fluid to relieve symptoms, but fluid may return. Ascites ...

Ascites is a common complication of cirrhosis. It happens due to the effects of portal hypertension and leads to fluid buildup in your abdomen. Ascites can be treated with medications, procedures, and ...

You may send us your comments on this form by clicking the button below. You will first be asked to supply your name, email address, and location. You must then acknowledge our data protection ...